






What are the uses of Naloxone Injection?
1. Reversal of Opioid-Induced Depression
2. Emergency Treatment of Opioid Overdose
3. Postoperative Opioid Reversal
4. Adjunctive Use in Septic Shock
Postoperative Use Risks
Cardiovascular Caution
Pulmonary Edema Risk
How to Use Naloxone Injection (400 mcg/ml):
Routes of Administration
Opioid Overdose (Adults)
Postoperative Opioid Depression
Intravenous Infusion
Important Mixing Precautions
Septic Shock
Side Effects of Naloxone Injection
In Postoperative Patients
During Opioid Overdose Reversal
In Opioid-Dependent Patients
Abrupt reversal may cause acute withdrawal, including:
In newborns, withdrawal may include:
Other Side Effects of Naloxone Injection
| System | Side Effects |
|---|---|
| Heart | Pulmonary edema, cardiac arrest, fast/irregular heartbeat |
| Digestive | Nausea, vomiting |
| Nervous System | Seizures, tingling (paraesthesia) |
| Mental Health | Agitation, hallucinations, tremors |
| Breathing | Difficulty breathing, low oxygen levels |
| Skin | Sweating, injection site reactions |
| Blood Vessels | High/low blood pressure, flushing or hot flashes |
Store at a temperature not exceeding 25°C. Protect from light.
5 × 1 ml Ampoule
Naloxone Hydrochloride Injection 0.4 mg/ml is available as 1 ml in an Amber Blue Dot glass ampoule. Such 5 glass ampoules in a unit carton with a pack insert.
Contact us directly to receive full information on the product, the formulation, the science behind it, stability data, and more. Our Business Development Manager is a click away.
Questions are useful tools, they open lines of communication; give us information; improve interactions, facilitate analysis, and many more.
A pharma CMO is a special kind of an organization, offering contract manufacturing services to pharmaceutical companies for various kinds of drug formulations.
Reduce overall costs and time to market :
Contract manufacturers already have the needed infrastructure and technical staff, so working with a CMO or CDMO can decrease the cost of manufacturing your pharmaceutical products.
Scalability and flexible production capacity :
You can produce what you need when you need it without worrying about excess capacity. Additionally, CMOs understand the importance of quality and compliance, so you don't have to sacrifice safety for scalability.
Save on upgrading and maintaining equipment :
If you have your manufacturing facility, you’ll have to pay to upgrade your equipment as technology advances—which can get expensive. A CMO/CDMO’s only function is to make and distribute products, so part of their core business responsibility is to update their equipment whenever needed and perform maintenance.
Ease supply chain issues :
During the pandemic, there were several instances of supply chain issues, including medicine shortages. CMOs are generally better equipped than startups to handle a supply chain crisis.
Bandwidth to focus on core competencies
When your company resources aren’t directly allocated to manufacturing and distribution, you have more time to focus on other tasks, like marketing your new drug, researching, or working on drug discovery.
We have 7+ manufacturing sites with a minimum of WHO GMP certification and other country-specific approvals like NAFDAC approved, PPK Kenya Approved, TFDA Tanzania Approved, EU-GMP Approved.
We have below manufacturing capacity:
For Tablet, Capsule, and soft gel: up to 1 million units per shift
For Syrup: up to 0.05 Million per shift
For Ampoule and Vial: up to 0.1 million units per shift
For Ointment and Cream: up to 0.1 million units per shift
For Suppository: 0.1 Million units per shift